191 filings
Page 6 of 10
8-K
IKT
Inhibikase Therapeutics Inc
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
EFFECT
IKT
Inhibikase Therapeutics Inc
14 Feb 22
Notice of effectiveness
12:15am
SC 13G/A
Milton H. Werner
11 Feb 22
Inhibikase Therapeutics / Werner Milton H. ownership change
5:15pm
UPLOAD
IKT
Inhibikase Therapeutics Inc
9 Feb 22
Letter from SEC
12:00am
CORRESP
IKT
Inhibikase Therapeutics Inc
9 Feb 22
Correspondence with SEC
12:00am
S-3
IKT
Inhibikase Therapeutics Inc
7 Feb 22
Shelf registration
12:00am
8-K
IKT
Inhibikase Therapeutics Inc
20 Jan 22
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 1Q 2022 BUSINESS PRESENTATION IKT
4:10pm
SC 13D
FiveT Investment Management Ltd
11 Jan 22
Inhibikase Therapeutics / FiveT Investment Management ownership change
12:04pm
4
IKT
Inhibikase Therapeutics Inc
4 Jan 22
Inhibikase Therapeutics / Milton H. Werner ownership change
9:25pm
SC 13D
FiveT Investment Management Ltd
15 Dec 21
Inhibikase Therapeutics / FiveT Investment Management ownership change
12:52pm
4
Milton H. Werner
19 Nov 21
Inhibikase Therapeutics / Milton H. Werner ownership change
8:13am
10-Q
2021 Q3
IKT
Inhibikase Therapeutics Inc
Quarterly report
15 Nov 21
4:33pm
8-K
IKT
Inhibikase Therapeutics Inc
19 Oct 21
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 4Q 2021 BUSINESS PRESENTATION IKT
5:03pm
S-8
IKT
Inhibikase Therapeutics Inc
15 Sep 21
Registration of securities for employees
4:55pm
8-K
IKT
Inhibikase Therapeutics Inc
8 Sep 21
Other Events
3:46pm
4
IKT
Inhibikase Therapeutics Inc
19 Aug 21
Inhibikase Therapeutics / Milton H. Werner ownership change
7:46am
8-K
IKT
Inhibikase Therapeutics Inc
17 Aug 21
Regulation FD Disclosure
5:02pm
10-Q
2021 Q2
IKT
Inhibikase Therapeutics Inc
Quarterly report
16 Aug 21
4:16pm
4
IKT
Inhibikase Therapeutics Inc
29 Jun 21
Inhibikase Therapeutics / Elizabeth G. O'Farrell ownership change
7:12pm
4
IKT
Inhibikase Therapeutics Inc
29 Jun 21
Inhibikase Therapeutics / PAUL C GRINT ownership change
7:11pm